DJIA 18,132.70 -81.72 -0.45%
NASDAQ 4,963.53 -24.36 -0.49%
S&P 500 2,104.50 -6.24 -0.30%
market minute promo

Roche Holding Ltd. (ADR) (NASDAQOTH: RHHBY)

34.13 0.27 (0.80%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

RHHBY $34.13 0.80%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $34.03
Previous Close $33.86
Daily Range $33.83 - $34.20
52-Week Range $32.29 - $38.71
Market Cap $191.8B
P/E Ratio 0.00
Dividend (Yield) $0.00 (2.6%)
Volume 1,956,229
Average Daily Volume 2,468,543
Current FY EPS $1.92

Sector

Healthcare

Industry

Pharma

Roche Holding Ltd. (ADR) (RHHBY) Description

Website:

News & Commentary Rss Feed

Why Pharmacyclics, Inc. Soared Higher Today

Pharmacyclics soars higher following reports that the company may put itself up for sale.

The 3 Biggest Disappointments This Earnings Season

Some companies posted earnings (or outlooks) that missed the market's expectations. Here are three that really caught our attention.

Why PDL BioPharma Inc. Stock Burst Today

PDLI BioPharma shares slumped today following fourth quarter results.

3 Tiny Biotech Stocks That I'm Paying Attention to in 2015

Achillion Pharmaceuticals Inc., Neuralstem Inc., and Prothena Corp. Plc could all announce news this year that could make shares climb or fall.

Pssst... Pfizer Just Told Investors That This is the Next Big Thing

Pfizer Inc.'s acquisition of Hospira could signal that investors should embrace biosimilar drugmakers.

Could This Disruptive New Technology Lead to a Cure for Cancer?

Major drugmakers are investing heavily in a disruptive technology that could lead to game-changing breakthroughs in the treatment of cancer. Here's what you need to know.

Why Shares of Exelixis, Inc. Briefly Spiked Higher

Exelixis shares popped briefly Thursday. Here's why.

Has Pfizer Inc. Finally Solved Its Immuno-oncology Problem?

Pfizer has jumped into the promising field of cancer immunotherapy with both feet. Is this effort too little, too late for the pharma giant?

Upcoming FDA Decisions We're Most Excited About

Three Motley Fool experts tell readers what upcoming FDA decisions have caught their eye.

The Small-Cap Biotech Stock You Should Be Watching

Motley Fool experts offer up insight into three intriguing small-cap biotech stocks.

See More RHHBY News...

RHHBY's Top Competitors

RHHBY $34.13 (0.80%)
Current stock: RHHBY
JNJ $102.51 (-0.28%)
Current stock: JNJ
NVS $102.40 (-0.58%)
Current stock: NVS
GSK $47.42 (-0.88%)
Current stock: GSK